Ranjan, T.; Podder, V.; Margolin, K.; Velcheti, V.; Maharaj, A.; Ahluwalia, M.S.
Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions. Cancers 2024, 16, 3388.
https://doi.org/10.3390/cancers16193388
AMA Style
Ranjan T, Podder V, Margolin K, Velcheti V, Maharaj A, Ahluwalia MS.
Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions. Cancers. 2024; 16(19):3388.
https://doi.org/10.3390/cancers16193388
Chicago/Turabian Style
Ranjan, Tulika, Vivek Podder, Kim Margolin, Vamsidhar Velcheti, Arun Maharaj, and Manmeet Singh Ahluwalia.
2024. "Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions" Cancers 16, no. 19: 3388.
https://doi.org/10.3390/cancers16193388
APA Style
Ranjan, T., Podder, V., Margolin, K., Velcheti, V., Maharaj, A., & Ahluwalia, M. S.
(2024). Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions. Cancers, 16(19), 3388.
https://doi.org/10.3390/cancers16193388
